BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chow KL, Tse KY, Cheung CL, Wong KW, Cheung AN, Wong RW, Chan AN, Yuen NW, Ngan HY, Ip PP. The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study. Histopathology 2017;70:746-55. [PMID: 27864989 DOI: 10.1111/his.13124] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Momeni-Boroujeni A, Yousefi E, Balakrishnan R, Riviere S, Kertowidjojo E, Hensley ML, Ladanyi M, Ellenson LH, Chiang S. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis. Mod Pathol 2023;36:100084. [PMID: 36788080 DOI: 10.1016/j.modpat.2022.100084] [Reference Citation Analysis]
2 Liu H, Wong C, Wong C, Liu F. Uterine smooth muscle tumor of uncertain malignant potential: A review of current knowledge. Taiwanese Journal of Obstetrics and Gynecology 2022;61:935-940. [DOI: 10.1016/j.tjog.2022.08.003] [Reference Citation Analysis]
3 Guo E, Li C, Hu Y, Zhao K, Zheng Q, Wang L. Leiomyoma with Bizarre Nuclei: A Current Update. IJWH 2022;Volume 14:1641-1656. [DOI: 10.2147/ijwh.s388278] [Reference Citation Analysis]
4 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
5 Chiang S. Mesenchymal Tumors, Pathology of the Uterine Corpus. Encyclopedia of Pathology 2022. [DOI: 10.1007/978-3-319-28845-1_5626-1] [Reference Citation Analysis]
6 Travaglino A, Raffone A, Santoro A, Raimondo D, Improda FP, Cariati F, De Marco M, Casadio P, Seracchioli R, Zullo F, Insabato L, Zannoni GF. Risk of Recurrence in Uterine Leiomyoma with Bizarre Nuclei: a Systematic Review and Meta-Analysis. Geburtshilfe Frauenheilkd 2021;81:1217-23. [PMID: 34754271 DOI: 10.1055/a-1533-1651] [Reference Citation Analysis]
7 Whaley RD, Thompson LDR. Epstein-Barr Virus-Associated Smooth Muscle Tumors of Larynx: A Clinicopathologic Study and Comprehensive Literature Review of 12 Cases. Head Neck Pathol 2021;15:1162-71. [PMID: 33891274 DOI: 10.1007/s12105-021-01328-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Travaglino A, Raffone A, Gencarelli A, Caldarelli C, Granata M, Santoro A, Zannoni GF, Mollo A, Zullo F, Insabato L. Stanford parameters stratify the risk of recurrence in gynecologic smooth muscle tumors of uncertain malignant potential. APMIS 2021;129:283-90. [PMID: 33786917 DOI: 10.1111/apm.13135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cotrino I, Carosso A, Macchi C, Baima Poma C, Cosma S, Ribotta M, Viora E, Sciarrone A, Borella F, Zola P. Ultrasound and clinical characteristics of uterine smooth muscle tumors of uncertain malignant potential (STUMPs). Eur J Obstet Gynecol Reprod Biol 2020;251:167-72. [PMID: 32505056 DOI: 10.1016/j.ejogrb.2020.05.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Ganesan R. Uterine smooth muscle tumour of uncertain malignant potential (STUMP): Where are we now? Case Rep Womens Health 2020;26:e00176. [PMID: 32055453 DOI: 10.1016/j.crwh.2020.e00176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Leonel ECR, Campos SGP, Bedolo CMB, Guerra LHA, Vilamaior PSL, Calmon MF, Rahal P, Amorim CA, Taboga SR. Perinatal exposure to bisphenol A impacts in the mammary gland morphology of adult Mongolian gerbils. Exp Mol Pathol 2020;113:104374. [PMID: 31917966 DOI: 10.1016/j.yexmp.2020.104374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lai CPT, Yeong JPS, Tan AS, Ong CHC, Lee B, Lim JCT, Thike AA, Iqbal J, Dent RA, Lim EH, Tan PH. Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence. Breast Cancer Res Treat 2019;178:295-305. [PMID: 31410680 DOI: 10.1007/s10549-019-05396-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
13 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Khieu ML, Broadwater DR, Aden JK, Coviello JM, Lynch DT, Hall JM. The Utility of Phosphohistone H3 (PHH3) in Follicular Lymphoma Grading: A Comparative Study With Ki-67 and H&E Mitotic Count. Am J Clin Pathol 2019;151:542-50. [PMID: 30788495 DOI: 10.1093/ajcp/aqz003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Zhang J, Xiong L, Tang W, Tang L, Wang B. Hypoxic culture enhances the expansion of rat bone marrow-derived mesenchymal stem cells via the regulatory pathways of cell division and apoptosis. In Vitro Cell Dev Biol Anim 2018;54:666-76. [PMID: 30136033 DOI: 10.1007/s11626-018-0281-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ohashi R, Namimatsu S, Sakatani T, Naito Z, Takei H, Shimizu A. Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3: OHASHI et al.. J Surg Oncol. [DOI: 10.1002/jso.25152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
17 Hao Q, Dai C, Deng Y, Xu P, Tian T, Lin S, Wang M, Liu K, Song D, Wu Y, Guo Y, Dai Z. Pooling analysis on prognostic value of PHH3 expression in cancer patients. Cancer Manag Res 2018;10:2279-88. [PMID: 30104898 DOI: 10.2147/CMAR.S167569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
18 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
19 Ip PP, Lim D, Cheung ANY, Oliva E. Immunoexpression of p16 in uterine leiomyomas with infarct-type necrosis: an analysis of 35 cases. Histopathology 2017;71:743-50. [DOI: 10.1111/his.13282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]